Back
Nippon Telegraph & Telephone Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
33
NTTYY
Nippon Telegraph & Telephone
Last Price:
$27.68
Seasonality Move:
2.1%
Sell
45
APLS
Apellis Pharmaceuticals
Last Price:
$18.50
Seasonality Move:
0.23%
Sell
33
Nippon Telegraph & Telephone (NTTYY)
is a Sell
Is Nippon Telegraph & Telephone a Buy, Sell or Hold?
-
The current Nippon Telegraph & Telephone [NTTYY] share price is $27.67. The Score for NTTYY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NTTYY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $18.82. The Score for APLS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTTYY Stock Price Chart
What is Nippon Telegraph & Telephone's stock price today?
-
The Nippon Telegraph & Telephone share price today is $27.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTTYY is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $18.82The current trend is relatively stagnant and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
NTTYY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 66.36 | Buy |
Chaikin Money Flow: | -28442 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.03 - 27.07) | Buy |
Bollinger Bands (100): | (24.14 - 26.18) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 53.88 | Buy |
Chaikin Money Flow: | -1855597 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.92 - 19.1) | Buy |
Bollinger Bands (100): | (18.54 - 28.54) | Sell |
NTTYY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.04 | Buy |
20-day SMA: | 26.65 | Buy |
50-day SMA: | 25.82 | Buy |
200-day SMA: | 25.26 | Buy |
8-day EMA: | 27.21 | Buy |
20-day EMA: | 26.74 | Buy |
50-day EMA: | 26.08 | Buy |
200-day EMA: | 25.61 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.65 | Buy |
20-day SMA: | 17.62 | Buy |
50-day SMA: | 19.15 | Sell |
200-day SMA: | 28 | Sell |
8-day EMA: | 17.92 | Buy |
20-day EMA: | 17.93 | Buy |
50-day EMA: | 19.59 | Sell |
200-day EMA: | 28.02 | Sell |
Nippon Telegraph & Telephone Earnings Growth & NTTYY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.17 per share, and an increase next year of $1.21 per share.
Nippon Telegraph & Telephone Technical Analysis
May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |